Target intelligence / Profile preview

GOT2 pseudogene 7 (GOT2P7)

Target: GOT2P7
Molecular classification: Other (Pseudogene)

Overview

GOT2 pseudogene 7 (GOT2P7) is a non-protein-coding pseudogene derived from the ancestral gene GOT2, which encodes glutamic-oxaloacetic transaminase 2, a pyridoxal phosphate-dependent mitochondrial enzyme involved in amino acid metabolism and the malate-aspartate shuttle. However, as a pseudogene, GOT2P7 does not encode a functional protein and is not considered a therapeutic target. There are no known roles in cell signaling, disease, or drug interaction[4].

Other names: GOT2P7glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) pseudogeneglutamic-oxaloacetic transaminase 2 pseudogene 7

Beyond the preview

Go deeper on GOT2 pseudogene 7 (GOT2P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GOT2 pseudogene 7 (GOT2P7).

Explore the full profile